Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Robust expression of tumor suppressor miRNA’s let-7 and miR-195 detected in plasma of Saudi female breast cancer patients

Fig. 1

Circulating miRNAs showing differential levels in breast cancer patients (Triple negative and Luminal) with respect to disease-free individuals. Three main groups: TNBC vs. healthy controls (Group A; eight significantly regulated miRNAs); luminal patients vs. healthy controls (Group B; five significantly regulated miRNAs); and breast cancer patients irrespective of subtype and healthy controls (Group C; five significantly regulated miRNAs)

Back to article page